本页面由Tiger Trade Technology Pte. Ltd.提供服务

Altimmune, Inc.

2.60
-0.0100-0.38%
成交量:67.76万
成交额:175.61万
市值:5.04亿
市盈率:-3.42
高:2.63
开:2.59
低:2.57
收:2.61
52周最高:6.44
52周最低:2.55
股本:1.94亿
流通股本:1.64亿
量比:0.56
换手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):-0.7600
每股收益(LYR):-0.9999
净资产收益率:-28.87%
总资产收益率:-17.20%
市净率:1.06
市盈率(LYR):-2.60

数据加载中...

2026/09/29

重要事件披露

Form 8-K - Current report
2026/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/07/28

重要事件披露

Form 8-K - Current report
2026/06/17

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/24

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report
2026/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/05

重要事件披露

Form 8-K - Current report
2026/02/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/04

重要事件披露

Form 8-K - Current report